Login / Signup

A clinical pharmacokinetic drug-drug interaction study between dextromethorphan and emvododstat, a potent anti-SARS-CoV-2 dihydroorotate dehydrogenase inhibitor.

Terri L MortonOscar L LaskinDiksha KaushikLucy LeeJiyuan MaCristian M BarAllan KristensenKylie O'KeefeLee GoldenMatthew KleinRonald Kong
Published in: European journal of clinical pharmacology (2023)
EudraCT 2021-004626-29, 11 May 2021.
Keyphrases
  • sars cov
  • adverse drug